RU2616609C2 - Антибиотические производные 2-оксо-оксазолидин-3, 5-диила - Google Patents
Антибиотические производные 2-оксо-оксазолидин-3, 5-диила Download PDFInfo
- Publication number
- RU2616609C2 RU2616609C2 RU2014123109A RU2014123109A RU2616609C2 RU 2616609 C2 RU2616609 C2 RU 2616609C2 RU 2014123109 A RU2014123109 A RU 2014123109A RU 2014123109 A RU2014123109 A RU 2014123109A RU 2616609 C2 RU2616609 C2 RU 2616609C2
- Authority
- RU
- Russia
- Prior art keywords
- oxo
- dihydro
- oxazolidin
- ylmethyl
- cyclopropyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Detergent Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2011054968 | 2011-11-08 | ||
| IBPCT/IB2011/054968 | 2011-11-08 | ||
| PCT/IB2012/056236 WO2013068948A1 (en) | 2011-11-08 | 2012-11-07 | 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2014123109A RU2014123109A (ru) | 2015-12-20 |
| RU2616609C2 true RU2616609C2 (ru) | 2017-04-18 |
Family
ID=47258051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014123109A RU2616609C2 (ru) | 2011-11-08 | 2012-11-07 | Антибиотические производные 2-оксо-оксазолидин-3, 5-диила |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9079922B2 (enExample) |
| EP (1) | EP2776431B1 (enExample) |
| JP (1) | JP6030146B2 (enExample) |
| KR (1) | KR20140096337A (enExample) |
| AR (1) | AR088691A1 (enExample) |
| AU (1) | AU2012335207B2 (enExample) |
| BR (1) | BR112014011064A8 (enExample) |
| CA (1) | CA2854264A1 (enExample) |
| CL (1) | CL2014001154A1 (enExample) |
| ES (1) | ES2581056T3 (enExample) |
| HK (1) | HK1202288A1 (enExample) |
| IL (1) | IL232463A0 (enExample) |
| IN (1) | IN2014CN04126A (enExample) |
| MX (1) | MX344529B (enExample) |
| PH (1) | PH12014500831A1 (enExample) |
| PL (1) | PL2776431T3 (enExample) |
| RU (1) | RU2616609C2 (enExample) |
| SG (1) | SG11201401710PA (enExample) |
| TW (1) | TWI594996B (enExample) |
| WO (1) | WO2013068948A1 (enExample) |
| ZA (1) | ZA201404176B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101294962B1 (ko) | 2008-10-07 | 2013-08-12 | 액테리온 파마슈티칼 리미티드 | 트리사이클 옥사졸리디논 항생제 화합물 |
| EA029361B1 (ru) | 2013-04-16 | 2018-03-30 | Идорсиа Фармасьютиклз Лтд | Антибактериальные биароматические производные |
| AR096135A1 (es) | 2013-05-02 | 2015-12-09 | Actelion Pharmaceuticals Ltd | Derivados de la quinolona |
| AR102256A1 (es) | 2014-10-15 | 2017-02-15 | Actelion Pharmaceuticals Ltd | Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi |
| MA41169A (fr) | 2014-12-17 | 2017-10-24 | Acraf | Composés antibactériens à large spectre d'activité |
| MA41168A (fr) | 2014-12-17 | 2017-10-24 | Acraf | Nouveaux composés antibactériens |
| GB201602235D0 (en) * | 2016-02-08 | 2016-03-23 | Redx Pharma Plc | Antibacterial compounds |
| US10487093B2 (en) | 2016-02-08 | 2019-11-26 | Redx Pharma Plc | Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds |
| EP3414246A1 (en) * | 2016-02-08 | 2018-12-19 | Redx Pharma PLC | Antibacterial compounds |
| DK3468975T3 (da) | 2016-06-08 | 2020-07-13 | Acraf | Nye antibakterielle forbindelser |
| TW201833120A (zh) | 2017-02-17 | 2018-09-16 | 瑞士商愛杜西亞製藥有限公司 | 芳基噁唑啶酮抗生素化合物 |
| EP3634968B1 (en) * | 2017-06-08 | 2023-01-25 | Bugworks Research, Inc. | Heterocyclic compounds useful as anti-bacterial agents and method for production thereof |
| WO2019106693A1 (en) * | 2017-11-29 | 2019-06-06 | Bugworks Research India Pvt Ltd | Anti-bacterial heterocyclic compounds and their synthesis |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009077989A1 (en) * | 2007-12-18 | 2009-06-25 | Actelion Pharmaceuticals Ltd | 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
| WO2009104159A1 (en) * | 2008-02-22 | 2009-08-27 | Actelion Pharmaceuticals Ltd | Oxazolidinone derivatives |
| RU2009121812A (ru) * | 2006-11-10 | 2010-12-20 | Актелион Фармасьютиклз Лтд (Ch) | Производные 5-гидроксиметилоксазолидин-2-она |
| RU2009141310A (ru) * | 2007-04-11 | 2011-05-20 | Актелион Фармасьютиклз Лтд (Ch) | Производные оксазолидиновых антибиотиков |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3149104A (en) | 1961-01-03 | 1964-09-15 | Sterling Drug Inc | 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters |
| CA1006521A (en) | 1972-12-18 | 1977-03-08 | Minoru Sugita | Piperazine derivatives and process for preparing them |
| SE444566B (sv) | 1977-09-20 | 1986-04-21 | Bellon Labor Sa Roger | 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav |
| GB1598915A (en) | 1977-09-20 | 1981-09-23 | Bellon Labor Sa Roger | 1,4-dihydro-quinoline-3-carboxylic acid derivatives process for their preparation and composition containing them |
| CS274601B2 (en) | 1983-07-27 | 1991-09-15 | Dainippon Pharmaceutical Co | Method of 1,8-naphthyridine derivative production |
| JPS62205060A (ja) | 1986-03-04 | 1987-09-09 | Kyorin Pharmaceut Co Ltd | ８位置換キノロンカルボン酸誘導体 |
| FI871419L (fi) | 1986-03-31 | 1987-10-01 | Sankyo Co | Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning. |
| JP2631854B2 (ja) | 1987-12-23 | 1997-07-16 | 藤本製薬株式会社 | 新規な１，８−ナフチリジン誘導体 |
| DE4301246A1 (de) | 1993-01-19 | 1994-07-21 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäurederivate |
| JPWO2004002973A1 (ja) | 2002-06-28 | 2005-10-27 | 株式会社カネカ | 光学活性１−置換アミノ−２，３−エポキシプロパンの製造方法並びにその合成中間体およびそれらの製造方法 |
| ES2308171T3 (es) * | 2003-04-30 | 2008-12-01 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones. |
| CA2549675C (en) * | 2003-12-18 | 2012-11-20 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Oxazolidinone-quinolone hybrid antibiotics |
| EP1771456A2 (fr) | 2004-07-30 | 2007-04-11 | Palumed SA | Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien |
| CA2578081A1 (en) | 2004-09-01 | 2006-03-09 | Ubitrak Inc. | System for gaming chip identification and counting |
| US20090156577A1 (en) | 2004-09-09 | 2009-06-18 | Benjamin Davis | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| WO2007118130A2 (en) | 2006-04-06 | 2007-10-18 | Glaxo Group Limited | Antibacterial agents |
| CL2008001002A1 (es) * | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
| KR101294962B1 (ko) | 2008-10-07 | 2013-08-12 | 액테리온 파마슈티칼 리미티드 | 트리사이클 옥사졸리디논 항생제 화합물 |
| CA2738775A1 (en) * | 2008-10-10 | 2010-04-15 | Actelion Pharmaceuticals Ltd | 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents |
| MX2011003188A (es) * | 2008-10-10 | 2011-04-27 | Actelion Pharmaceuticals Ltd | Antibioticos de oxazolidinilo. |
| TW201121965A (en) | 2009-09-28 | 2011-07-01 | Lg Life Sciences Ltd | Use of a quinolone derivative containing 7-(4-aminomethyl-3-oxime)pyrrolidine group that is capable of inducing granulocyte colony stimulating factor for treatment of neutropenia and recovery of hematopoiesis |
| CN101792443A (zh) | 2010-03-09 | 2010-08-04 | 北京欧凯纳斯科技有限公司 | 氟代喹诺酮衍生物及其制备方法和用途 |
-
2012
- 2012-11-07 JP JP2014540612A patent/JP6030146B2/ja not_active Expired - Fee Related
- 2012-11-07 MX MX2014005637A patent/MX344529B/es active IP Right Grant
- 2012-11-07 EP EP12791863.9A patent/EP2776431B1/en not_active Not-in-force
- 2012-11-07 BR BR112014011064A patent/BR112014011064A8/pt not_active Application Discontinuation
- 2012-11-07 US US14/356,896 patent/US9079922B2/en not_active Expired - Fee Related
- 2012-11-07 PL PL12791863.9T patent/PL2776431T3/pl unknown
- 2012-11-07 HK HK15102622.5A patent/HK1202288A1/xx unknown
- 2012-11-07 RU RU2014123109A patent/RU2616609C2/ru not_active IP Right Cessation
- 2012-11-07 IN IN4126CHN2014 patent/IN2014CN04126A/en unknown
- 2012-11-07 PH PH1/2014/500831A patent/PH12014500831A1/en unknown
- 2012-11-07 WO PCT/IB2012/056236 patent/WO2013068948A1/en not_active Ceased
- 2012-11-07 TW TW101141423A patent/TWI594996B/zh not_active IP Right Cessation
- 2012-11-07 SG SG11201401710PA patent/SG11201401710PA/en unknown
- 2012-11-07 KR KR1020147014957A patent/KR20140096337A/ko not_active Abandoned
- 2012-11-07 AR ARP120104192A patent/AR088691A1/es unknown
- 2012-11-07 AU AU2012335207A patent/AU2012335207B2/en not_active Ceased
- 2012-11-07 ES ES12791863.9T patent/ES2581056T3/es active Active
- 2012-11-07 CA CA2854264A patent/CA2854264A1/en not_active Abandoned
-
2014
- 2014-04-30 CL CL2014001154A patent/CL2014001154A1/es unknown
- 2014-05-05 IL IL232463A patent/IL232463A0/en unknown
- 2014-06-06 ZA ZA2014/04176A patent/ZA201404176B/en unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2009121812A (ru) * | 2006-11-10 | 2010-12-20 | Актелион Фармасьютиклз Лтд (Ch) | Производные 5-гидроксиметилоксазолидин-2-она |
| RU2009141310A (ru) * | 2007-04-11 | 2011-05-20 | Актелион Фармасьютиклз Лтд (Ch) | Производные оксазолидиновых антибиотиков |
| WO2009077989A1 (en) * | 2007-12-18 | 2009-06-25 | Actelion Pharmaceuticals Ltd | 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
| WO2009104159A1 (en) * | 2008-02-22 | 2009-08-27 | Actelion Pharmaceuticals Ltd | Oxazolidinone derivatives |
Non-Patent Citations (1)
| Title |
|---|
| C. Hubschwerlen et al. "Structure-Activity Relationship in the Oxazolidinone-Quinolone Hybrid Series: Influence of the Central Spacer on the AntibacterialActivityand the Mode of Action" Bioorganic & Medicinal Chemistry Letters vol.13, N23, 2003, 4229-4233. * |
Also Published As
| Publication number | Publication date |
|---|---|
| IN2014CN04126A (enExample) | 2015-07-10 |
| MX2014005637A (es) | 2014-06-23 |
| JP6030146B2 (ja) | 2016-11-24 |
| RU2014123109A (ru) | 2015-12-20 |
| TWI594996B (zh) | 2017-08-11 |
| CL2014001154A1 (es) | 2014-09-12 |
| KR20140096337A (ko) | 2014-08-05 |
| JP2014532754A (ja) | 2014-12-08 |
| AU2012335207B2 (en) | 2017-05-25 |
| EP2776431A1 (en) | 2014-09-17 |
| PL2776431T3 (pl) | 2016-11-30 |
| PH12014500831A1 (en) | 2019-08-07 |
| AU2012335207A1 (en) | 2014-07-03 |
| BR112014011064A2 (pt) | 2017-06-13 |
| IL232463A0 (en) | 2014-06-30 |
| ES2581056T3 (es) | 2016-08-31 |
| WO2013068948A1 (en) | 2013-05-16 |
| HK1202288A1 (en) | 2015-09-25 |
| BR112014011064A8 (pt) | 2017-12-26 |
| EP2776431B1 (en) | 2016-05-04 |
| SG11201401710PA (en) | 2014-09-26 |
| MX344529B (es) | 2016-12-19 |
| CN103917539A (zh) | 2014-07-09 |
| TW201326166A (zh) | 2013-07-01 |
| ZA201404176B (en) | 2016-05-25 |
| US9079922B2 (en) | 2015-07-14 |
| US20150051188A1 (en) | 2015-02-19 |
| CA2854264A1 (en) | 2013-05-16 |
| AR088691A1 (es) | 2014-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6030146B2 (ja) | ２−オキソ−オキサゾリジン−３，５−ジイル抗生物質誘導体 | |
| KR101495269B1 (ko) | 옥사졸리디논 항생물질 | |
| JP4484965B2 (ja) | ５−ヒドロキシメチル−オキサゾリジン−２−オン誘導体 | |
| US8916573B2 (en) | Quinazoline-2,4-dione derivatives | |
| JP2017537933A (ja) | 新規な抗菌性化合物 | |
| JP5490809B2 (ja) | オキサゾリジニル抗生物質 | |
| KR20160003244A (ko) | 퀴놀론 유도체 | |
| TW201429972A (zh) | 抗菌噁唑酮衍生物 | |
| CN103917539B (zh) | 2-氧代-噁唑烷-3,5-二基抗生素衍生物 | |
| US9487516B2 (en) | Antibacterial oxadiazolone derivatives | |
| EP3883937A1 (en) | Free amino compounds for the treatment and prophylaxis of bacterial infection | |
| CA3012567A1 (en) | Antibacterial compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC41 | Official registration of the transfer of exclusive right |
Effective date: 20171123 |
|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20191108 |